Provided by Tiger Fintech (Singapore) Pte. Ltd.

Birth Control

1,303.57
-20.7150-1.56%
Number of Gainers:1
Number of Losers:4
Number of Flat:1
PE:- -
High:1,347.28
Open:1,330.97
Low:1,289.98
Close:1,324.29
Loading ...

Generation Bio Elects Directors and Approves Key Proposals

TIPRANKS
·
9 hours ago

Generation Bio Co. Conducted Its Annual Stockholders Meeting

Reuters
·
9 hours ago

MannKind Corporation Unveils Presentation Highlighting Afrezza Growth, Strong Financials, and Pipeline Advancements

Reuters
·
10 hours ago

DarÉ Bioscience and Rosy Wellness Announce Strategic Collaboration to Educate and Market DarÉ’S Dare to Play Sildenafil Cream

THOMSON REUTERS
·
04 Jun

Teva Pharmaceutical Industries Raises Pool Tender Offer, Reports Early Tender Results

MT Newswires Live
·
03 Jun

Femasys Announces Public Offering and Private Placement

TIPRANKS
·
02 Jun

Femasys Inc. Announces Underwritten Offering of 3.6 Million Shares and Concurrent Private Placement of Over 1.6 Million Shares

Reuters
·
02 Jun

Teva announces results from a study of treatment patterns of tardive dyskinesia

TIPRANKS
·
02 Jun

Kyverna, Rocket, Teva, Fair Isaac, Oklo Trending by Analysts

TIPRANKS
·
31 May

New Data From Teva Shows Substantial Rates of Undertreated Tardive Dyskinesia in Long-Term Care Settings at Psych Congress Elevate 2025

THOMSON REUTERS
·
31 May

Femasys prices 3.6M shares at 85c in underwritten public offering

TIPRANKS
·
30 May

BRIEF-Femasys Announces Pricing Of Underwritten Public Offering And Concurrent Private Placement With Gross Proceeds Of $4.5 Million

Reuters
·
30 May

Femasys Inc - Prices Public Offering of 3.6 Mln Shares at $0.85/Share

THOMSON REUTERS
·
30 May

Femasys Announces Pricing of Underwritten Public Offering and Concurrent Private Placement With Gross Proceeds of $4.5 Million

THOMSON REUTERS
·
30 May

Teva Pharmaceutical (TEVA) Receives a Buy from UBS

TIPRANKS
·
30 May

BUZZ-Australia's Lynas Rare Earths gains on signing rare earths deal with Malaysian co

Reuters
·
30 May

Femasys Inc. Announces Public Offering of Common Stock and Concurrent Private Placement

Reuters
·
30 May

Femasys Announces Proposed Public Offering of Common Stock and Concurrent Private Placement

THOMSON REUTERS
·
30 May

Teva reaffirms ‘Pivot to Growth’ strategy with launch of acceleration phase

TIPRANKS
·
29 May

Teva Reaffirms “Pivot to Growth” Strategy Progress With Launch of Acceleration Phase at 2025 Innovation and Strategy Day

THOMSON REUTERS
·
29 May